Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Yes it's boring BUT
View:
Post by TommyNickels on Oct 24, 2024 3:06pm

Yes it's boring BUT

... People aren't dumping.

If you want shares ar this point, looks like you gotta slap the ASK.

Too many potential PRs to be on the sidelines.

BTD approval and we aren't priced anywhere near 35 cents.

Have a feeling we are going to see a little surge of buying to close the day.
Comment by Galaxym31 on Oct 24, 2024 3:27pm
.19 is boring .34 is  "Electric Avenue" listen to it on head phones .
Comment by TommyNickels on Oct 24, 2024 3:40pm
We want action. Not interested in pennies.
Comment by chry200030 on Oct 24, 2024 5:06pm
We get nickel and dimes until we get FDA approval in 2026. But all those nickel and dimes will add up over the next 24 months.. 
Comment by menoalittle on Oct 24, 2024 5:11pm
If/when we get BTD approval, it's entirely possible (and reasonable) to get AA in 2025.
Comment by Longholder99 on Oct 24, 2024 5:23pm
Or simultaneously 
Comment by Gooseybear on Oct 24, 2024 3:43pm
Naysayers will be left behind. Just saying from a 7 year bladder cancer survivor.
Comment by TommyNickels on Oct 24, 2024 4:03pm
Excellent. Theralase has the goods. Nice close for us. 12K bite taken out of thr 135 wall.
Comment by Galaxym31 on Oct 24, 2024 4:11pm
Could be a shark .
Comment by gordo323 on Oct 24, 2024 4:41pm
Nice close on low volume Level II   Theralase Technologies Inc. (CA:TLT) Size Bid Ask Size 10000 0.310 0.350 130000 4000 0.305 0.360 23500 18000 0.300 0.380 ...more  
Comment by TommyNickels on Oct 24, 2024 5:43pm
The guy who dumped down to 31.5 might be feeling a little foolish. Hope we open up tmro and push to 38. Then news Monday morning.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250